Abstract:Objective: Recent studies demonstrate circulating serum spexin levels are reduced in obesity or type 2 diabetes mellitus (T2DM) patients and may play a role in glucose metabolism. The mechanism underlying is not known. In this study, we explore whether spexin has a role in insulin resistance and hepatic glucose metabolism. Methods: The correlation between serum spexin levels and the homeostasis model assessment of insulin resistance (HOMA-IR) was studied in newly diagnosed T2DM patients. After intraperitoneal injection of exogenous spexin for 8 weeks, the effect of spexin on exogenous glucose infusion rates (GIR), and hepatic glucose production (HGP) were assessed by extended hyperinsulinemic-euglycemic clamp in high-fat-diet (HFD)-induced rats. Glucose concentration with CRISPR/Cas9-mediated disruption of spexin expression in HepG2 cells culture was observed. Expression of transcription factors (Forkhead box O1, FoxO1 and peroxisome proliferator-activated receptor gamma coactivator 1-alpha, PGC-1 alpha) and key enzymes (G-6-Pase and PEPCK) of gluconeogenesis pathway were observed in vitro and in vivo. Results: The serum spexin level was significantly low in newly diagnosed T2DM patients as compared with healthy patients and significantly negatively correlated with the HOMA-IR values. Exogenous spexin treatment resulted in weight loss and decrease of HOMA-IR value in high-fat-diet (HFD)-induced rats. The exogenous glucose infusion rates (GIR) were higher in the HFD + spexin group than that in the HFD group (358 +/- 32 vs. 285 +/- 24 mu mol/kg/min, P < 0.05). Steady-state hepatic glucose production (HGP) was also suppressed by similar to 50% in the HFD + spexin group as compared with that in the HFD group. Furthermore, spexin inhibited gluconeogenesis in dose-dependent and time-dependent manner in the insulin-resistant cell model. CRISPR/Cas9-mediated knockdown of spexin in HepG2 cells activated gluconeogenesis. Moreover, spexin was shown regulating gluconeogenesis by inhibiting FoxO1/PGC-1 alpha pathway, and key gluconeogenic enzymes, (PEPCK and G-6-Pase) in both HFD-induced rats and insulin-resistant cells. Conclusions: Spexin plays an important role in insulin resistance in HFD-induced rats and insulin-resistant cells. Regulation of the effects of spexin on insulin resistance may hold therapeutic value for metabolic diseases.

Serum Spexin Level Is Negatively Associated With Peripheral Neuropathy and Sensory Pain in Type 2 Diabetes

Spexin/NPQ Induces FBJ Osteosarcoma Oncogene (fos) and Produces Antinociceptive Effect Against Inflammatory Pain in the Mouse Model

Spexin Alleviates Insulin Resistance and Inhibits Hepatic Gluconeogenesis Via the FoxO1/PGC-1α Pathway in High-Fat-diet-induced Rats and Insulin Resistant Cells.

Serum Adiponectin Levels Are Positively Associated With Diabetic Peripheral Neuropathy in Chinese Patients With Type 2 Diabetes

Decreased Spinal Endomorphin-2 Contributes to Mechanical Allodynia in Streptozotocin-Induced Diabetic Rats

Serum brain-derived neurotrophic factor levels in patients with diabetic neuropathic pain

The effect of sinomenine in diabetic neuropathic pain mediated by the P2X receptor in dorsal root ganglia.

The effect of sinomenine in diabetic neuropathic pain mediated by the P2X 3 receptor in dorsal root ganglia

Serum Spexin Differed in Newly Diagnosed Type 2 Diabetes Patients According to Body Mass Index and Increased with the Improvement of Metabolic Status

Extracellular Signal-Regulated Protein Kinase Activation in Spinal Cord Contributes to Pain Hypersensitivity in a Mouse Model of Type 2 Diabetes

Lncrna NONRATT021972 Sirna Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia

Substance P Induces Inflammatory Responses Involving NF-κB in Genetically Diabetic Mice Skin Fibroblasts Co-Cultured with Macrophages.

Spinal P2X7R Contributes to Streptozotocin-Induced Mechanical Allodynia in Mice

Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy

Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes.

Novel hypothalamic pathways for metabolic effects of spexin

Effects of Subcutaneous Transfection of Human Beta-Nerve Growth Factor Gene on Expression of Substance P in Dorsal Root Ganglion in a Rat Model of Diabetic Neuropathic Pain

Infiltration of Blood-Derived Macrophages Contributes to the Development of Diabetic Neuropathy.

Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes

Serum Nesfatin-1 Is Reduced In Type 2 Diabetes Mellitus Patients With Peripheral Arterial Disease

Electroacupuncture alleviates diabetes-induced mechanical allodynia and downregulates bradykinin B1 receptor expression in spinal cord dorsal horn